Anna Gajos-Michniewicz

PARP1 inhibitor olaparib (Lynparza) exerts synthetic lethal effect against ligase 4-deficient melanomas

Reinhard Dummer, Kinga Majchrzak, Tomasz Sliwinski, 2016, Oncotarget.